Equus asinus breed Dezhou chromosome 24, ASM1607732v2, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Laurasiatheria; Perissodactyla; Equidae; Equus.
Donkey genomes provide new insights into domestication and selection for coat color
REFSEQ INFORMATION: The reference sequence is identical to\nCM027713.2.\nAssembly name: ASM1607732v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Dairy Cattle Research Center,\nShandong Academy of Agricultural Sciences on 2021/10/14. The\noriginal whole-genome shotgun project has the accession\nJADWZW000000000.2.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Dairy Cattle Research Center, Shandong\n Academy of Agricultural Sciences\nAssembly Method :: SOAPdenovo v. 2.04.4; DBG2OLC v. 1;\n 3D-DNA v. 170123\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 211.0x\nSequencing Technology :: Illumina HiSeq; PacBio Sequel; Hi-C\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Equus asinus Annotation Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF01960
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
COORDINATES: polyA evidence [ECO:0006239]
probable ATP-dependent RNA helicase DDX43
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: cyclic GMP-AMP synthase
mitochondrial tRNA translation optimization 1, transcript variant X1
mitochondrial tRNA translation optimization 1, transcript variant X2
mitochondrial tRNA translation optimization 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
protein MTO1 homolog, mitochondrial isoform X1
protein MTO1 homolog, mitochondrial isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
eukaryotic translation elongation factor 1 alpha 1
solute carrier family 17 member 5, transcript variant X2
solute carrier family 17 member 5, transcript variant X1
solute carrier family 17 member 5, transcript variant X5
solute carrier family 17 member 5, transcript variant X4
solute carrier family 17 member 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
uncharacterized LOC123280388, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC123280388, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
collagen type XII alpha 1 chain, transcript variant X1
collagen type XII alpha 1 chain, transcript variant X2
collagen type XII alpha 1 chain, transcript variant X3
cytochrome c oxidase subunit 7A2, mitochondrial
transmembrane protein 30A, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transmembrane protein 30A, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transmembrane protein 30A, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
transmembrane protein 30A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
cell cycle control protein 50A isoform X2
transmembrane protein 30A, transcript variant X10
transmembrane protein 30A, transcript variant X6
transmembrane protein 30A, transcript variant X5
transmembrane protein 30A, transcript variant X2
transmembrane protein 30A, transcript variant X3
transmembrane protein 30A, transcript variant X1
cell cycle control protein 50A isoform X1
filamin A interacting protein 1, transcript variant X4
filamin A interacting protein 1, transcript variant X2
filamin-A-interacting protein 1 isoform X2
filamin A interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
filamin A interacting protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
filamin-A-interacting protein 1 isoform X1
SUMO specific peptidase 6, transcript variant X1
SUMO specific peptidase 6, transcript variant X2
SUMO specific peptidase 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 12 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 71 samples with support for all annotated introns
interphotoreceptor matrix proteoglycan 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 42% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: interphotoreceptor matrix proteoglycan 1
CDGSH iron-sulfur domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
meiotic double-stranded break formation protein 4, transcript variant X2
meiotic double-stranded break formation protein 4, transcript variant X3
meiotic double-stranded break formation protein 4, transcript variant X4
meiotic double-stranded break formation protein 4, transcript variant X1
meiosis-specific protein MEI4 isoform X1
meiosis-specific protein MEI4 isoform X2
interleukin 1 receptor associated kinase 1 binding protein 1
interleukin-1 receptor-associated kinase 1-binding protein 1
uncharacterized LOC123280470, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123280470, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments
pleckstrin homology domain interacting protein, transcript variant X1
pleckstrin homology domain interacting protein, transcript variant X2
pleckstrin homology domain interacting protein, transcript variant X5
pleckstrin homology domain interacting protein, transcript variant X4
pleckstrin homology domain interacting protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
high mobility group nucleosomal binding domain 3, transcript variant X5
high mobility group nucleosomal binding domain 3, transcript variant X7
high mobility group nucleosomal binding domain 3, transcript variant X8
high mobility group nucleosomal binding domain 3, transcript variant X3
high mobility group nucleosomal binding domain 3, transcript variant X2
high mobility group nucleosome-binding domain-containing protein 3 isoform X6
high mobility group nucleosome-binding domain-containing protein 3 isoform X5
high mobility group nucleosome-binding domain-containing protein 3 isoform X3
high mobility group nucleosomal binding domain 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
high mobility group nucleosomal binding domain 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
high mobility group nucleosomal binding domain 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 83 samples with support for all annotated introns
high mobility group nucleosome-binding domain-containing protein 3 isoform X2
high mobility group nucleosome-binding domain-containing protein 3 isoform X4
high mobility group nucleosome-binding domain-containing protein 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123280413, transcript variant X2
uncharacterized LOC123280413, transcript variant X1
uncharacterized LOC123280485, transcript variant X1
uncharacterized LOC123280485, transcript variant X3
uncharacterized LOC123280485, transcript variant X2
SH3 domain binding glutamate rich protein like 2, transcript variant X3
SH3 domain-binding glutamic acid-rich-like protein 2 isoform X3
SH3 domain binding glutamate rich protein like 2, transcript variant X1
SH3 domain-binding glutamic acid-rich-like protein 2 isoform X1
SH3 domain binding glutamate rich protein like 2, transcript variant X4
SH3 domain-binding glutamic acid-rich-like protein 2 isoform X4
SH3 domain binding glutamate rich protein like 2, transcript variant X2
SH3 domain-binding glutamic acid-rich-like protein 2 isoform X2
elongation of very long chain fatty acids protein 4
uncharacterized LOC123280377, transcript variant X1
uncharacterized LOC123280377, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TTK protein kinase, transcript variant X2
TTK protein kinase, transcript variant X3
TTK protein kinase, transcript variant X4
TTK protein kinase, transcript variant X1
dual specificity protein kinase TTK isoform X2
dual specificity protein kinase TTK isoform X3
dual specificity protein kinase TTK isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
branched chain keto acid dehydrogenase E1 subunit beta, transcript variant X1
branched chain keto acid dehydrogenase E1 subunit beta, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
branched chain keto acid dehydrogenase E1 subunit beta, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
branched chain keto acid dehydrogenase E1 subunit beta, transcript variant X5
branched chain keto acid dehydrogenase E1 subunit beta, transcript variant X3
branched chain keto acid dehydrogenase E1 subunit beta, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
branched chain keto acid dehydrogenase E1 subunit beta, transcript variant X2
2-oxoisovalerate dehydrogenase subunit beta, mitochondrial isoform X2
2-oxoisovalerate dehydrogenase subunit beta, mitochondrial isoform X1
2-oxoisovalerate dehydrogenase subunit beta, mitochondrial isoform X3
uncharacterized LOC123280340, transcript variant X3
uncharacterized LOC123280340, transcript variant X2
uncharacterized LOC123280340, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC123280460, transcript variant X1
uncharacterized LOC123280460, transcript variant X2
uncharacterized LOC106842945, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC106842945, transcript variant X2
uncharacterized LOC106842945, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123280486, transcript variant X2
uncharacterized LOC123280486, transcript variant X1
uncharacterized LOC123280486, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123280486, transcript variant X4
uncharacterized LOC123280395, transcript variant X1
uncharacterized LOC123280395, transcript variant X2
terminal nucleotidyltransferase 5A, transcript variant X2
terminal nucleotidyltransferase 5A, transcript variant X1
terminal nucleotidyltransferase 5A isoform X1
terminal nucleotidyltransferase 5A isoform X2
inhibitor of Bruton tyrosine kinase, transcript variant X3
inhibitor of Bruton tyrosine kinase isoform X3
inhibitor of Bruton tyrosine kinase, transcript variant X6
inhibitor of Bruton tyrosine kinase, transcript variant X4
inhibitor of Bruton tyrosine kinase, transcript variant X2
inhibitor of Bruton tyrosine kinase, transcript variant X1
inhibitor of Bruton tyrosine kinase isoform X2
inhibitor of Bruton tyrosine kinase isoform X1
inhibitor of Bruton tyrosine kinase isoform X4
inhibitor of Bruton tyrosine kinase isoform X5
inhibitor of Bruton tyrosine kinase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 20% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 5% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
DOP1 leucine zipper like protein A, transcript variant X1
DOP1 leucine zipper like protein A, transcript variant X6
DOP1 leucine zipper like protein A, transcript variant X7
DOP1 leucine zipper like protein A, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
DOP1 leucine zipper like protein A, transcript variant X3
DOP1 leucine zipper like protein A, transcript variant X4
DOP1 leucine zipper like protein A, transcript variant X2
DOP1 leucine zipper like protein A, transcript variant X5
phosphoglucomutase 3, transcript variant X2
phosphoglucomutase 3, transcript variant X3
phosphoacetylglucosamine mutase isoform X2
phosphoacetylglucosamine mutase isoform X3
phosphoglucomutase 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
phosphoacetylglucosamine mutase isoform X4
phosphoglucomutase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 80 samples with support for all annotated introns
phosphoacetylglucosamine mutase isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: NADP-dependent malic enzyme
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
serine protease 35, transcript variant X3
serine protease 35, transcript variant X2
serine protease 35, transcript variant X1
synaptosome associated protein 91, transcript variant X6
synaptosome associated protein 91, transcript variant X5
synaptosome associated protein 91, transcript variant X3
synaptosome associated protein 91, transcript variant X7
synaptosome associated protein 91, transcript variant X22
synaptosome associated protein 91, transcript variant X23
synaptosome associated protein 91, transcript variant X20
synaptosome associated protein 91, transcript variant X14
synaptosome associated protein 91, transcript variant X11
synaptosome associated protein 91, transcript variant X8
synaptosome associated protein 91, transcript variant X19
synaptosome associated protein 91, transcript variant X21
synaptosome associated protein 91, transcript variant X18
synaptosome associated protein 91, transcript variant X17
synaptosome associated protein 91, transcript variant X13
synaptosome associated protein 91, transcript variant X9
synaptosome associated protein 91, transcript variant X10
synaptosome associated protein 91, transcript variant X15
synaptosome associated protein 91, transcript variant X1
synaptosome associated protein 91, transcript variant X16
synaptosome associated protein 91, transcript variant X4
synaptosome associated protein 91, transcript variant X12
synaptosome associated protein 91, transcript variant X2
clathrin coat assembly protein AP180 isoform X9
clathrin coat assembly protein AP180 isoform X8
clathrin coat assembly protein AP180 isoform X15
clathrin coat assembly protein AP180 isoform X16
clathrin coat assembly protein AP180 isoform X13
clathrin coat assembly protein AP180 isoform X7
clathrin coat assembly protein AP180 isoform X5
clathrin coat assembly protein AP180 isoform X2
clathrin coat assembly protein AP180 isoform X12
clathrin coat assembly protein AP180 isoform X14
clathrin coat assembly protein AP180 isoform X11
clathrin coat assembly protein AP180 isoform X10
clathrin coat assembly protein AP180 isoform X6
clathrin coat assembly protein AP180 isoform X3
clathrin coat assembly protein AP180 isoform X4
clathrin coat assembly protein AP180 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
cytochrome b5 reductase 4, transcript variant X1
cytochrome b5 reductase 4, transcript variant X2
cytochrome b5 reductase 4, transcript variant X3
melanocortin 2 receptor accessory protein 2, transcript variant X3
melanocortin 2 receptor accessory protein 2, transcript variant X1
melanocortin-2 receptor accessory protein 2 isoform X1
melanocortin-2 receptor accessory protein 2 isoform X3
melanocortin 2 receptor accessory protein 2, transcript variant X2
melanocortin-2 receptor accessory protein 2 isoform X2
centrosomal protein 162, transcript variant X4
centrosomal protein 162, transcript variant X5
centrosomal protein 162, transcript variant X1
centrosomal protein 162, transcript variant X3
centrosomal protein 162, transcript variant X2
centrosomal protein of 162 kDa isoform X5
centrosomal protein of 162 kDa isoform X2
centrosomal protein of 162 kDa isoform X3
centrosomal protein of 162 kDa isoform X4
centrosomal protein of 162 kDa isoform X1
centrosomal protein 162, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
centrosomal protein of 162 kDa isoform X6
centrosomal protein 162, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
centrosomal protein 162, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
T-box transcription factor 18, transcript variant X1
T-box transcription factor 18, transcript variant X3
T-box transcription factor 18, transcript variant X2
T-box transcription factor TBX18 isoform X1
T-box transcription factor TBX18 isoform X3
T-box transcription factor TBX18 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 99% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123280479, transcript variant X1
uncharacterized LOC123280479, transcript variant X5
uncharacterized LOC123280479, transcript variant X3
uncharacterized LOC123280479, transcript variant X2
uncharacterized LOC123280479, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 47% coverage of the annotated genomic feature by RNAseq alignments
synaptotagmin binding cytoplasmic RNA interacting protein, transcript variant X5
synaptotagmin binding cytoplasmic RNA interacting protein, transcript variant X4
synaptotagmin binding cytoplasmic RNA interacting protein, transcript variant X3
synaptotagmin binding cytoplasmic RNA interacting protein, transcript variant X2
heterogeneous nuclear ribonucleoprotein Q isoform X5
heterogeneous nuclear ribonucleoprotein Q isoform X4
heterogeneous nuclear ribonucleoprotein Q isoform X3
heterogeneous nuclear ribonucleoprotein Q isoform X2
synaptotagmin binding cytoplasmic RNA interacting protein, transcript variant X1
synaptotagmin binding cytoplasmic RNA interacting protein, transcript variant X7
synaptotagmin binding cytoplasmic RNA interacting protein, transcript variant X6
heterogeneous nuclear ribonucleoprotein Q isoform X1
heterogeneous nuclear ribonucleoprotein Q isoform X6
uncharacterized LOC106829134, transcript variant X3
uncharacterized LOC106829134, transcript variant X4
uncharacterized LOC106829134, transcript variant X5
uncharacterized LOC106829134, transcript variant X1
uncharacterized LOC106829134, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00278
uncharacterized LOC106829137, transcript variant X1
uncharacterized LOC106829137, transcript variant X3
uncharacterized LOC106829137, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
glycoprotein hormones, alpha polypeptide
LOW QUALITY PROTEIN: glycoprotein hormones alpha chain
LOW QUALITY PROTEIN: zinc finger protein 292
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein C6orf163 homolog
uncharacterized LOC123280431, transcript variant X2
uncharacterized LOC123280431, transcript variant X1
cilia and flagella associated protein 206, transcript variant X2
cilia and flagella associated protein 206, transcript variant X1
cilia- and flagella-associated protein 206 isoform X1
cilia and flagella associated protein 206, transcript variant X8
cilia and flagella associated protein 206, transcript variant X4
cilia- and flagella-associated protein 206 isoform X2
cilia and flagella associated protein 206, transcript variant X6
cilia and flagella associated protein 206, transcript variant X11
cilia and flagella associated protein 206, transcript variant X7
cilia and flagella associated protein 206, transcript variant X3
cilia and flagella associated protein 206, transcript variant X10
cilia and flagella associated protein 206, transcript variant X12
cilia- and flagella-associated protein 206 isoform X4
cilia and flagella associated protein 206, transcript variant X9
cilia and flagella associated protein 206, transcript variant X5
cilia- and flagella-associated protein 206 isoform X3
cilia- and flagella-associated protein 206 isoform X5
cilia- and flagella-associated protein 206 isoform X6
solute carrier family 35 member A1, transcript variant X1
solute carrier family 35 member A1, transcript variant X3
solute carrier family 35 member A1, transcript variant X2
arginyl-tRNA synthetase 2, mitochondrial
LOW QUALITY PROTEIN: probable arginine--tRNA ligase, mitochondrial
origin recognition complex subunit 3, transcript variant X4
origin recognition complex subunit 3, transcript variant X1
origin recognition complex subunit 3, transcript variant X2
origin recognition complex subunit 3, transcript variant X3
origin recognition complex subunit 3 isoform X1
origin recognition complex subunit 3 isoform X2
origin recognition complex subunit 3 isoform X3
origin recognition complex subunit 3 isoform X4
uncharacterized LOC106835838, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC106835838, transcript variant X2
uncharacterized LOC106835838, transcript variant X1
uncharacterized LOC106835838, transcript variant X3
uncharacterized LOC106835838, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC106835838, transcript variant X6
sperm acrosome membrane-associated protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
RNA guanylyltransferase and 5'-phosphatase, transcript variant X3
RNA guanylyltransferase and 5'-phosphatase, transcript variant X2
RNA guanylyltransferase and 5'-phosphatase, transcript variant X1
RNA guanylyltransferase and 5'-phosphatase, transcript variant X4
RNA guanylyltransferase and 5'-phosphatase, transcript variant X5
uncharacterized LOC123280359, transcript variant X1
uncharacterized LOC123280359, transcript variant X3
uncharacterized LOC123280359, transcript variant X2
proline rich nuclear receptor coactivator 1
proline-rich nuclear receptor coactivator 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments
serine and arginine rich splicing factor 12, transcript variant X1
serine and arginine rich splicing factor 12, transcript variant X2
serine and arginine rich splicing factor 12, transcript variant X3
serine and arginine rich splicing factor 12, transcript variant X4
serine/arginine-rich splicing factor 12 isoform X1
serine/arginine-rich splicing factor 12 isoform X2
peptidase M20 domain-containing protein 2
gamma-aminobutyric acid type A receptor subunit rho1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit rho-1 isoform X1
gamma-aminobutyric acid type A receptor subunit rho1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gamma-aminobutyric acid receptor subunit rho-1 isoform X2
gamma-aminobutyric acid type A receptor subunit rho2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 15 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid receptor subunit rho-2
ubiquitin conjugating enzyme E2 J1, transcript variant X2
ubiquitin conjugating enzyme E2 J1, transcript variant X1
ubiquitin-conjugating enzyme E2 J1 isoform X2
ubiquitin-conjugating enzyme E2 J1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 33% coverage of the annotated genomic feature by RNAseq alignments
Ras related GTP binding D, transcript variant X1
Ras related GTP binding D, transcript variant X2
ras-related GTP-binding protein D isoform X1
ras-related GTP-binding protein D isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat domain 6, transcript variant X3
ankyrin repeat domain 6, transcript variant X4
ankyrin repeat domain 6, transcript variant X9
ankyrin repeat domain 6, transcript variant X8
ankyrin repeat domain-containing protein 6 isoform X3
ankyrin repeat domain-containing protein 6 isoform X4
ankyrin repeat domain-containing protein 6 isoform X9
ankyrin repeat domain-containing protein 6 isoform X8
ankyrin repeat domain 6, transcript variant X1
ankyrin repeat domain 6, transcript variant X2
ankyrin repeat domain 6, transcript variant X7
ankyrin repeat domain 6, transcript variant X5
ankyrin repeat domain 6, transcript variant X10
ankyrin repeat domain 6, transcript variant X6
ankyrin repeat domain-containing protein 6 isoform X1
ankyrin repeat domain-containing protein 6 isoform X2
ankyrin repeat domain-containing protein 6 isoform X7
ankyrin repeat domain-containing protein 6 isoform X5
ankyrin repeat domain-containing protein 6 isoform X10
ankyrin repeat domain-containing protein 6 isoform X6
LYR motif containing 2, transcript variant X2
LYR motif-containing protein 2 isoform X2
LYR motif containing 2, transcript variant X1
LYR motif-containing protein 2 isoform X1
caspase 8 associated protein 2, transcript variant X3
caspase 8 associated protein 2, transcript variant X4
caspase 8 associated protein 2, transcript variant X1
caspase 8 associated protein 2, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: gap junction alpha-10 protein
BTB domain and CNC homolog 2, transcript variant X3
BTB domain and CNC homolog 2, transcript variant X2
BTB domain and CNC homolog 2, transcript variant X1
BTB domain and CNC homolog 2, transcript variant X4
uncharacterized LOC123280352, transcript variant X1
uncharacterized LOC123280352, transcript variant X2
uncharacterized LOC123280352, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase 7, transcript variant X1
mitogen-activated protein kinase kinase kinase 7, transcript variant X3
mitogen-activated protein kinase kinase kinase 7, transcript variant X4
mitogen-activated protein kinase kinase kinase 7, transcript variant X2
mitogen-activated protein kinase kinase kinase 7 isoform X3
mitogen-activated protein kinase kinase kinase 7 isoform X2
mitogen-activated protein kinase kinase kinase 7 isoform X1
uncharacterized LOC123280355, transcript variant X2
uncharacterized LOC123280355, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
uncharacterized LOC123280424, transcript variant X2
uncharacterized LOC123280424, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC106832467, transcript variant X3
uncharacterized LOC106832467, transcript variant X2
uncharacterized LOC106832467, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
mannosidase endo-alpha, transcript variant X5
mannosidase endo-alpha, transcript variant X4
glycoprotein endo-alpha-1,2-mannosidase isoform X2
mannosidase endo-alpha, transcript variant X1
mannosidase endo-alpha, transcript variant X2
mannosidase endo-alpha, transcript variant X3
glycoprotein endo-alpha-1,2-mannosidase isoform X1
uncharacterized LOC123280494, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123280494, transcript variant X1
uncharacterized LOC123280494, transcript variant X3
fucosyltransferase 9, transcript variant X2
fucosyltransferase 9, transcript variant X1
4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9
four and a half LIM domains 5, transcript variant X4
four and a half LIM domains 5, transcript variant X3
four and a half LIM domains 5, transcript variant X1
four and a half LIM domains 5, transcript variant X5
four and a half LIM domains 5, transcript variant X2
four and a half LIM domains 5, transcript variant X6
G protein-coupled receptor 63, transcript variant X1
G protein-coupled receptor 63, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
G protein-coupled receptor 63, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
G protein-coupled receptor 63, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
G protein-coupled receptor 63, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
G protein-coupled receptor 63, transcript variant X2
NADH:ubiquinone oxidoreductase complex assembly factor 4
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4
kelch like family member 32, transcript variant X25
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
kelch like family member 32, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
kelch like family member 32, transcript variant X22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
kelch like family member 32, transcript variant X23
kelch like family member 32, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
kelch like family member 32, transcript variant X10
kelch like family member 32, transcript variant X12
kelch like family member 32, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
kelch like family member 32, transcript variant X14
kelch like family member 32, transcript variant X13
kelch like family member 32, transcript variant X1
kelch like family member 32, transcript variant X5
kelch like family member 32, transcript variant X9
kelch like family member 32, transcript variant X2
kelch like family member 32, transcript variant X8
kelch like family member 32, transcript variant X3
kelch like family member 32, transcript variant X7
kelch like family member 32, transcript variant X4
kelch like family member 32, transcript variant X6
kelch like family member 32, transcript variant X20
kelch like family member 32, transcript variant X19
kelch like family member 32, transcript variant X18
kelch like family member 32, transcript variant X16
kelch like family member 32, transcript variant X17
kelch like family member 32, transcript variant X26
kelch like family member 32, transcript variant X24
uncharacterized LOC123280392, transcript variant X1
uncharacterized LOC123280392, transcript variant X2
LOW QUALITY PROTEIN: POU domain, class 3, transcription factor 2
F-box and leucine rich repeat protein 4, transcript variant X2
F-box and leucine rich repeat protein 4, transcript variant X1
uncharacterized LOC123280399, transcript variant X2
uncharacterized LOC123280399, transcript variant X1
failed axon connections homolog, metaxin like GST domain containing, transcript variant X3
failed axon connections homolog, metaxin like GST domain containing, transcript variant X2
failed axon connections homolog, metaxin like GST domain containing, transcript variant X4
failed axon connections homolog, metaxin like GST domain containing, transcript variant X1
failed axon connections homolog isoform X1
failed axon connections homolog isoform X2
failed axon connections homolog isoform X3
coenzyme Q3, methyltransferase, transcript variant X2
coenzyme Q3, methyltransferase, transcript variant X1
ubiquinone biosynthesis O-methyltransferase, mitochondrial isoform X2
ubiquinone biosynthesis O-methyltransferase, mitochondrial isoform X1
PNN interacting serine and arginine rich protein, transcript variant X1
PNN interacting serine and arginine rich protein, transcript variant X2
arginine/serine-rich protein PNISR isoform X2
arginine/serine-rich protein PNISR isoform X1
PNN interacting serine and arginine rich protein, transcript variant X3
arginine/serine-rich protein PNISR isoform X3
uncharacterized LOC123280389, transcript variant X2
uncharacterized LOC123280389, transcript variant X1
uncharacterized LOC123280389, transcript variant X3
ubiquitin specific peptidase 45, transcript variant X2
ubiquitin specific peptidase 45, transcript variant X1
ubiquitin specific peptidase 45, transcript variant X6
ubiquitin carboxyl-terminal hydrolase 45 isoform X2
ubiquitin carboxyl-terminal hydrolase 45 isoform X1
ubiquitin carboxyl-terminal hydrolase 45 isoform X5
ubiquitin specific peptidase 45, transcript variant X4
ubiquitin specific peptidase 45, transcript variant X3
ubiquitin specific peptidase 45, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 45 isoform X3
ubiquitin carboxyl-terminal hydrolase 45 isoform X4
ubiquitin specific peptidase 45, transcript variant X7
ubiquitin carboxyl-terminal hydrolase 45 isoform X6
thiosulfate sulfurtransferase like domain containing 3
thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
melanin concentrating hormone receptor 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
melanin-concentrating hormone receptor 2
SIM bHLH transcription factor 1, transcript variant X1
SIM bHLH transcription factor 1, transcript variant X2
activating signal cointegrator 1 complex subunit 3, transcript variant X1
activating signal cointegrator 1 complex subunit 3, transcript variant X2
activating signal cointegrator 1 complex subunit 3, transcript variant X4
activating signal cointegrator 1 complex subunit 3, transcript variant X3
activating signal cointegrator 1 complex subunit 3 isoform X1
activating signal cointegrator 1 complex subunit 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
glutamate ionotropic receptor kainate type subunit 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 25 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
glutamate receptor ionotropic, kainate 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 1% coverage of the annotated genomic feature by RNAseq alignments
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1
LOW QUALITY PROTEIN: E3 ubiquitin-protein ligase HACE1
blood vessel epicardial substance, transcript variant X1
blood vessel epicardial substance, transcript variant X2
popeye domain containing 3, transcript variant X2
popeye domain containing 3, transcript variant X1
uncharacterized LOC123280344, transcript variant X3
uncharacterized LOC123280344, transcript variant X7
uncharacterized LOC123280344, transcript variant X6
uncharacterized LOC123280344, transcript variant X5
uncharacterized LOC123280344, transcript variant X2
uncharacterized LOC123280344, transcript variant X1
uncharacterized LOC123280344, transcript variant X9
uncharacterized LOC123280344, transcript variant X4
uncharacterized LOC123280344, transcript variant X8
uncharacterized LOC123280344, transcript variant X10
prolyl endopeptidase, transcript variant X1
prolyl endopeptidase, transcript variant X2
uncharacterized LOC106843678, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC106843678, transcript variant X1
uncharacterized LOC123280444, transcript variant X1
uncharacterized LOC123280444, transcript variant X2
uncharacterized LOC123280444, transcript variant X4
uncharacterized LOC123280444, transcript variant X5
uncharacterized LOC123280444, transcript variant X3
PR domain zinc finger protein 1 isoform X3
PR domain zinc finger protein 1 isoform X1
PR domain zinc finger protein 1 isoform X2
autophagy related 5, transcript variant X4
autophagy related 5, transcript variant X7
autophagy related 5, transcript variant X3
autophagy related 5, transcript variant X1
autophagy related 5, transcript variant X2
autophagy related 5, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
autophagy related 5, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
crystallin beta-gamma domain containing 1, transcript variant X2
crystallin beta-gamma domain containing 1, transcript variant X1
beta/gamma crystallin domain-containing protein 1 isoform X1
beta/gamma crystallin domain-containing protein 1 isoform X2
crystallin beta-gamma domain containing 1, transcript variant X3
beta/gamma crystallin domain-containing protein 1 isoform X3
crystallin beta-gamma domain containing 1, transcript variant X4
beta/gamma crystallin domain-containing protein 1 isoform X4
reticulon 4 interacting protein 1, transcript variant X5
reticulon 4 interacting protein 1, transcript variant X4
reticulon 4 interacting protein 1, transcript variant X3
reticulon 4 interacting protein 1, transcript variant X1
reticulon-4-interacting protein 1, mitochondrial isoform X3
reticulon-4-interacting protein 1, mitochondrial isoform X4
reticulon-4-interacting protein 1, mitochondrial isoform X1
reticulon 4 interacting protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
reticulon-4-interacting protein 1, mitochondrial isoform X2
glutaminyl-tRNA amidotransferase subunit QRSL1
glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial
uncharacterized LOC123280453, transcript variant X2
uncharacterized LOC123280453, transcript variant X1
uncharacterized LOC123280484, transcript variant X1
uncharacterized LOC123280484, transcript variant X3
uncharacterized LOC123280484, transcript variant X4
uncharacterized LOC123280484, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF01294
mitochondrial transcription rescue factor 1, transcript variant X2
mitochondrial transcription rescue factor 1, transcript variant X3
mitochondrial transcription rescue factor 1, transcript variant X1
mitochondrial transcription rescue factor 1
BEN domain containing 3, transcript variant X1
BEN domain containing 3, transcript variant X2
decaprenyl diphosphate synthase subunit 2, transcript variant X1
decaprenyl diphosphate synthase subunit 2, transcript variant X3
all trans-polyprenyl-diphosphate synthase PDSS2 isoform X3
all trans-polyprenyl-diphosphate synthase PDSS2 isoform X1
decaprenyl diphosphate synthase subunit 2, transcript variant X2
all trans-polyprenyl-diphosphate synthase PDSS2 isoform X2
decaprenyl diphosphate synthase subunit 2, transcript variant X5
decaprenyl diphosphate synthase subunit 2, transcript variant X4
all trans-polyprenyl-diphosphate synthase PDSS2 isoform X4
sine oculis binding protein homolog, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sine oculis binding protein homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sine oculis binding protein homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sine oculis binding protein homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
sine oculis binding protein homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
sine oculis binding protein homolog, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
sine oculis binding protein homolog, transcript variant X6
sine oculis binding protein homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sine oculis binding protein homolog, transcript variant X8
sine oculis binding protein homolog, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sine oculis-binding protein homolog isoform X1
sine oculis-binding protein homolog isoform X2
sine oculis binding protein homolog, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sine oculis-binding protein homolog isoform X3
sine oculis binding protein homolog, transcript variant X12
sine oculis-binding protein homolog isoform X4
Scm polycomb group protein like 4, transcript variant X1
Scm polycomb group protein like 4, transcript variant X2
Scm polycomb group protein like 4, transcript variant X3
Scm polycomb group protein like 4, transcript variant X5
Scm polycomb group protein like 4, transcript variant X6
Scm polycomb group protein like 4, transcript variant X4
sex comb on midleg-like protein 4 isoform X1
sex comb on midleg-like protein 4 isoform X2
sex comb on midleg-like protein 4 isoform X3
sex comb on midleg-like protein 4 isoform X4
SEC63 homolog, protein translocation regulator, transcript variant X1
SEC63 homolog, protein translocation regulator, transcript variant X2
translocation protein SEC63 homolog isoform X2
translocation protein SEC63 homolog isoform X1
wiskott-Aldrich syndrome protein homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
osteoclastogenesis associated transmembrane protein 1, transcript variant X1
osteoclastogenesis associated transmembrane protein 1, transcript variant X2
osteopetrosis-associated transmembrane protein 1
nuclear receptor subfamily 2 group E member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 59 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC123280443, transcript variant X1
uncharacterized LOC123280443, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
armadillo repeat containing 2, transcript variant X2
armadillo repeat containing 2, transcript variant X5
armadillo repeat containing 2, transcript variant X3
armadillo repeat containing 2, transcript variant X1
armadillo repeat containing 2, transcript variant X4
armadillo repeat-containing protein 2 isoform X1
armadillo repeat-containing protein 2 isoform X2
centrosomal protein 57 like 1, transcript variant X2
centrosomal protein 57 like 1, transcript variant X3
centrosomal protein 57 like 1, transcript variant X1
centrosomal protein 57 like 1, transcript variant X4
uncharacterized LOC106829732, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC106829732, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC106829732 isoform X1
uncharacterized protein LOC106829732 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
peptidylprolyl isomerase like 6, transcript variant X2
peptidylprolyl isomerase like 6, transcript variant X1
probable inactive peptidyl-prolyl cis-trans isomerase-like 6 isoform X2
probable inactive peptidyl-prolyl cis-trans isomerase-like 6 isoform X1
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X2
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X6
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X5
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X1
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X4
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X7
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X3
zinc finger and BTB domain containing 24, transcript variant X1
zinc finger and BTB domain containing 24, transcript variant X2
zinc finger and BTB domain-containing protein 24 isoform X1
zinc finger and BTB domain containing 24, transcript variant X3
zinc finger and BTB domain containing 24, transcript variant X5
zinc finger and BTB domain containing 24, transcript variant X6
zinc finger and BTB domain containing 24, transcript variant X4
zinc finger and BTB domain-containing protein 24 isoform X2
uncharacterized LOC123280353, transcript variant X2
uncharacterized LOC123280353, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 10 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
WASP family member 1, transcript variant X3
WASP family member 1, transcript variant X4
WASP family member 1, transcript variant X2
WASP family member 1, transcript variant X1
wiskott-Aldrich syndrome protein family member 1 isoform X2
wiskott-Aldrich syndrome protein family member 1 isoform X1
cell division cycle 40, transcript variant X2
cell division cycle 40, transcript variant X1
pre-mRNA-processing factor 17 isoform X1
pre-mRNA-processing factor 17 isoform X2
LOW QUALITY PROTEIN: methyltransferase-like protein 24
D-aspartate oxidase, transcript variant X1
D-aspartate oxidase, transcript variant X6
D-aspartate oxidase, transcript variant X3
D-aspartate oxidase, transcript variant X2
D-aspartate oxidase, transcript variant X5
D-aspartate oxidase, transcript variant X4
cyclin dependent kinase 19, transcript variant X2
cyclin dependent kinase 19, transcript variant X1
cyclin dependent kinase 19, transcript variant X7
cyclin dependent kinase 19, transcript variant X4
cyclin dependent kinase 19, transcript variant X8
cyclin dependent kinase 19, transcript variant X5
cyclin dependent kinase 19, transcript variant X6
cyclin dependent kinase 19, transcript variant X10
cyclin dependent kinase 19, transcript variant X9
cyclin dependent kinase 19, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
S-adenosylmethionine decarboxylase proenzyme
general transcription factor IIIC subunit 6, transcript variant X1
general transcription factor IIIC subunit 6, transcript variant X2
general transcription factor IIIC subunit 6, transcript variant X3
general transcription factor IIIC subunit 6, transcript variant X4
general transcription factor IIIC subunit 6, transcript variant X5
general transcription factor 3C polypeptide 6
ribosome production factor 2 homolog, transcript variant X1
ribosome production factor 2 homolog isoform X1
ribosome production factor 2 homolog, transcript variant X2
ribosome production factor 2 homolog isoform X2
solute carrier family 16 member 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
monocarboxylate transporter 10 isoform X1
solute carrier family 16 member 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
monocarboxylate transporter 10 isoform X2
uncharacterized LOC123280505, transcript variant X1
uncharacterized LOC123280505, transcript variant X2
major facilitator superfamily domain containing 4B
LOW QUALITY PROTEIN: sodium-dependent glucose transporter 1
REV3 like, DNA directed polymerase zeta catalytic subunit
LOW QUALITY PROTEIN: DNA polymerase zeta catalytic subunit
collagen alpha-1(III) chain-like, transcript variant X1
collagen alpha-1(III) chain-like, transcript variant X4
collagen alpha-1(III) chain-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
collagen alpha-1(III) chain-like, transcript variant X3
collagen alpha-1(III) chain-like, transcript variant X5
collagen alpha-1(III) chain-like, transcript variant X2
uncharacterized protein LOC106847054 isoform X4
collagen alpha-1(III) chain-like isoform X6
uncharacterized protein LOC106847054 isoform X1
uncharacterized protein LOC106847054 isoform X3
uncharacterized protein LOC106847054 isoform X5
uncharacterized protein LOC106847054 isoform X2
TRAF3 interacting protein 2, transcript variant X2
TRAF3 interacting protein 2, transcript variant X1
FYN proto-oncogene, Src family tyrosine kinase, transcript variant X4
FYN proto-oncogene, Src family tyrosine kinase, transcript variant X5
FYN proto-oncogene, Src family tyrosine kinase, transcript variant X1
FYN proto-oncogene, Src family tyrosine kinase, transcript variant X2
FYN proto-oncogene, Src family tyrosine kinase, transcript variant X3
uncharacterized LOC106847049, transcript variant X1
uncharacterized LOC106847049, transcript variant X3
uncharacterized LOC106847049, transcript variant X2
cellular communication network factor 6, transcript variant X1
cellular communication network factor 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cellular communication network factor 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cellular communication network factor 6 isoform X1
cellular communication network factor 6 isoform X3
cellular communication network factor 6 isoform X2
tubulin epsilon 1, transcript variant X1
tubulin epsilon 1, transcript variant X3
tubulin epsilon 1, transcript variant X2
family with sequence similarity 229 member B, transcript variant X8
family with sequence similarity 229 member B, transcript variant X7
family with sequence similarity 229 member B, transcript variant X14
family with sequence similarity 229 member B, transcript variant X6
family with sequence similarity 229 member B, transcript variant X1
family with sequence similarity 229 member B, transcript variant X4
family with sequence similarity 229 member B, transcript variant X10
family with sequence similarity 229 member B, transcript variant X3
family with sequence similarity 229 member B, transcript variant X9
family with sequence similarity 229 member B, transcript variant X15
family with sequence similarity 229 member B, transcript variant X20
family with sequence similarity 229 member B, transcript variant X12
family with sequence similarity 229 member B, transcript variant X18
family with sequence similarity 229 member B, transcript variant X5
family with sequence similarity 229 member B, transcript variant X2
family with sequence similarity 229 member B, transcript variant X19
family with sequence similarity 229 member B, transcript variant X11
family with sequence similarity 229 member B, transcript variant X16
family with sequence similarity 229 member B, transcript variant X17
family with sequence similarity 229 member B, transcript variant X13
laminin subunit alpha 4, transcript variant X2
laminin subunit alpha 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC106847082, transcript variant X2
uncharacterized LOC106847082, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 32% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 9% coverage of the annotated genomic feature by RNAseq alignments
myristoylated alanine rich protein kinase C substrate
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: myristoylated alanine-rich C-kinase substrate
heparan sulfate-glucosamine 3-sulfotransferase 5
heparan sulfate glucosamine 3-O-sulfotransferase 5
uncharacterized LOC123280468, transcript variant X1
uncharacterized LOC123280468, transcript variant X2
uncharacterized LOC123280468, transcript variant X3
5'-nucleotidase domain containing 1, transcript variant X3
5'-nucleotidase domain containing 1, transcript variant X2
5'-nucleotidase domain containing 1, transcript variant X1
5'-nucleotidase domain-containing protein 1 isoform X1
5'-nucleotidase domain-containing protein 1 isoform X2
5'-nucleotidase domain-containing protein 1 isoform X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: collagen alpha-1(X) chain
uncharacterized LOC106847039, transcript variant X2
uncharacterized LOC106847039, transcript variant X3
uncharacterized LOC106847039, transcript variant X1
testis-specific Y-encoded-like protein 4
testis-specific Y-encoded-like protein 1
uncharacterized LOC123280454, transcript variant X2
uncharacterized LOC123280454, transcript variant X1
dermatan sulfate epimerase, transcript variant X4
dermatan sulfate epimerase, transcript variant X3
dermatan sulfate epimerase, transcript variant X1
dermatan sulfate epimerase, transcript variant X5
dermatan sulfate epimerase, transcript variant X2
dermatan sulfate epimerase, transcript variant X6
dermatan sulfate epimerase, transcript variant X7
calcium homeostasis modulator family member 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 87% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: calcium homeostasis modulator protein 6
trafficking protein particle complex subunit 3L
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
trafficking protein particle complex subunit 3-like protein
calcium homeostasis modulator family member 5, transcript variant X1
calcium homeostasis modulator family member 5, transcript variant X2
calcium homeostasis modulator family member 5, transcript variant X3
calcium homeostasis modulator family member 5, transcript variant X4
calcium homeostasis modulator protein 5 isoform X1
calcium homeostasis modulator protein 5 isoform X2
calcium homeostasis modulator family member 4
RWD domain containing 1, transcript variant X1
RWD domain containing 1, transcript variant X5
RWD domain containing 1, transcript variant X3
RWD domain-containing protein 1 isoform X1
RWD domain containing 1, transcript variant X4
RWD domain containing 1, transcript variant X2
RWD domain-containing protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: amine sulfotransferase-like
radial spoke head component 4A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
radial spoke head component 4A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
radial spoke head component 4A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
radial spoke head protein 4 homolog A isoform X1
radial spoke head protein 4 homolog A isoform X3
radial spoke head protein 4 homolog A isoform X2
zinc finger containing ubiquitin peptidase 1, transcript variant X2
zinc finger containing ubiquitin peptidase 1, transcript variant X1
zinc finger containing ubiquitin peptidase 1, transcript variant X3
zinc finger containing ubiquitin peptidase 1, transcript variant X4
zinc finger-containing ubiquitin peptidase 1 isoform X1
zinc finger-containing ubiquitin peptidase 1 isoform X3
zinc finger-containing ubiquitin peptidase 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
karyopherin subunit alpha 5, transcript variant X1
karyopherin subunit alpha 5, transcript variant X2
karyopherin subunit alpha 5, transcript variant X4
karyopherin subunit alpha 5, transcript variant X7
karyopherin subunit alpha 5, transcript variant X6
karyopherin subunit alpha 5, transcript variant X3
karyopherin subunit alpha 5, transcript variant X5
karyopherin subunit alpha 5, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
family with sequence similarity 162 member B
G protein-coupled receptor class C group 6 member A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
G protein-coupled receptor class C group 6 member A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
G protein-coupled receptor class C group 6 member A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 45% coverage of the annotated genomic feature by RNAseq alignments
G-protein coupled receptor family C group 6 member A isoform X3
G-protein coupled receptor family C group 6 member A isoform X2
G-protein coupled receptor family C group 6 member A isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
vestigial like family member 2, transcript variant X3
vestigial like family member 2, transcript variant X1
vestigial like family member 2, transcript variant X2
transcription cofactor vestigial-like protein 2 isoform X2
transcription cofactor vestigial-like protein 2 isoform X1
transcription cofactor vestigial-like protein 2 isoform X3
ROS proto-oncogene 1, receptor tyrosine kinase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
proto-oncogene tyrosine-protein kinase ROS
discoidin, CUB and LCCL domain containing 1, transcript variant X1
discoidin, CUB and LCCL domain-containing protein 1 isoform X1
discoidin, CUB and LCCL domain containing 1, transcript variant X2
discoidin, CUB and LCCL domain-containing protein 1 isoform X2
golgi associated PDZ and coiled-coil motif containing, transcript variant X2
golgi associated PDZ and coiled-coil motif containing, transcript variant X1
Golgi-associated PDZ and coiled-coil motif-containing protein isoform X2
Golgi-associated PDZ and coiled-coil motif-containing protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 33% coverage of the annotated genomic feature by RNAseq alignments
NUS1 dehydrodolichyl diphosphate synthase subunit
dehydrodolichyl diphosphate synthase complex subunit NUS1
centrosomal protein 85 like, transcript variant X1
centrosomal protein 85 like, transcript variant X2
centrosomal protein 85 like, transcript variant X3
centrosomal protein 85 like, transcript variant X4
centrosomal protein 85 like, transcript variant X5
centrosomal protein of 85 kDa-like isoform X1
centrosomal protein of 85 kDa-like isoform X2
centrosomal protein of 85 kDa-like isoform X3
centrosomal protein of 85 kDa-like isoform X4
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X2
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X1
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X3
anti-silencing function 1A histone chaperone
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
minichromosome maintenance 9 homologous recombination repair factor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
family with sequence similarity 184 member A
mannosyl-oligosaccharide 1,2-alpha-mannosidase IA
acidic leucine-rich nuclear phosphoprotein 32 family member B-like
LOW QUALITY PROTEIN: acidic leucine-rich nuclear phosphoprotein 32 family member B-like
uncharacterized LOC123280458, transcript variant X1
uncharacterized LOC123280458, transcript variant X3
uncharacterized LOC123280458, transcript variant X2
uncharacterized LOC123280400, transcript variant X1
uncharacterized LOC123280400, transcript variant X2
TBC1 domain family member 32, transcript variant X5
TBC1 domain family member 32, transcript variant X3
TBC1 domain family member 32, transcript variant X4
TBC1 domain family member 32, transcript variant X1
TBC1 domain family member 32, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
TBC1 domain family member 32, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
TBC1 domain family member 32, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123280357, transcript variant X1
uncharacterized LOC123280357, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
uncharacterized LOC106842770, transcript variant X4
uncharacterized LOC106842770, transcript variant X2
uncharacterized LOC106842770, transcript variant X1
uncharacterized LOC106842770, transcript variant X3
heat shock transcription factor 2, transcript variant X1
heat shock transcription factor 2, transcript variant X2
heat shock transcription factor 2, transcript variant X3
uncharacterized LOC123280326, transcript variant X2
uncharacterized LOC123280326, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
cAMP-dependent protein kinase inhibitor beta, transcript variant X8
cAMP-dependent protein kinase inhibitor beta, transcript variant X3
cAMP-dependent protein kinase inhibitor beta, transcript variant X6
cAMP-dependent protein kinase inhibitor beta, transcript variant X2
cAMP-dependent protein kinase inhibitor beta, transcript variant X1
cAMP-dependent protein kinase inhibitor beta, transcript variant X4
cAMP-dependent protein kinase inhibitor beta isoform X1
cAMP-dependent protein kinase inhibitor beta isoform X2
cAMP-dependent protein kinase inhibitor beta, transcript variant X5
cAMP-dependent protein kinase inhibitor beta, transcript variant X7
cAMP-dependent protein kinase inhibitor beta isoform X3
cAMP-dependent protein kinase inhibitor beta isoform X4
sphingomyelin phosphodiesterase acid like 3A, transcript variant X1
acid sphingomyelinase-like phosphodiesterase 3a isoform X1
sphingomyelin phosphodiesterase acid like 3A, transcript variant X2
acid sphingomyelinase-like phosphodiesterase 3a isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC106838721, transcript variant X3
uncharacterized LOC106838721, transcript variant X1
uncharacterized LOC106838721, transcript variant X2
sodium/potassium transporting ATPase interacting 2, transcript variant X1
sodium/potassium transporting ATPase interacting 2, transcript variant X2
sodium/potassium transporting ATPase interacting 2, transcript variant X3
sodium/potassium-transporting ATPase subunit beta-1-interacting protein 2
uncharacterized LOC123280348, transcript variant X1
uncharacterized LOC123280348, transcript variant X2
uncharacterized LOC123280350, transcript variant X1
uncharacterized LOC123280350, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 20% coverage of the annotated genomic feature by RNAseq alignments
probable E3 ubiquitin-protein ligase RNF217
HD domain containing 2, transcript variant X3
HD domain containing 2, transcript variant X1
HD domain containing 2, transcript variant X4
HD domain containing 2, transcript variant X2
uncharacterized LOC106842001, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 70% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC106842001, transcript variant X1
hes related family bHLH transcription factor with YRPW motif 2
hairy/enhancer-of-split related with YRPW motif protein 2
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
nuclear receptor coactivator 7, transcript variant X3
nuclear receptor coactivator 7, transcript variant X2
nuclear receptor coactivator 7, transcript variant X1
nuclear receptor coactivator 7, transcript variant X5
nuclear receptor coactivator 7, transcript variant X4
nuclear receptor coactivator 7, transcript variant X6
nuclear receptor coactivator 7, transcript variant X7
nuclear receptor coactivator 7 isoform X1
nuclear receptor coactivator 7 isoform X2
nuclear receptor coactivator 7 isoform X3
nuclear receptor coactivator 7, transcript variant X8
nuclear receptor coactivator 7 isoform X4
histidine triad nucleotide binding protein 3
histidine triad nucleotide-binding protein 3
tRNA methyltransferase 11 homolog, transcript variant X2
tRNA (guanine(10)-N2)-methyltransferase homolog isoform X2
tRNA methyltransferase 11 homolog, transcript variant X1
tRNA (guanine(10)-N2)-methyltransferase homolog isoform X1
tRNA methyltransferase 11 homolog, transcript variant X3
tRNA (guanine(10)-N2)-methyltransferase homolog isoform X3
centromere protein W, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 79% coverage of the annotated genomic feature by RNAseq alignments
centromere protein W, transcript variant X1
uncharacterized LOC123280422, transcript variant X1
uncharacterized LOC123280422, transcript variant X2
uncharacterized LOC123280422, transcript variant X4
uncharacterized LOC123280422, transcript variant X3
uncharacterized LOC123280422, transcript variant X5
ring finger protein 146, transcript variant X7
ring finger protein 146, transcript variant X1
ring finger protein 146, transcript variant X5
ring finger protein 146, transcript variant X9
ring finger protein 146, transcript variant X3
ring finger protein 146, transcript variant X6
ring finger protein 146, transcript variant X8
ring finger protein 146, transcript variant X2
ring finger protein 146, transcript variant X4
E3 ubiquitin-protein ligase RNF146 isoform X2
E3 ubiquitin-protein ligase RNF146 isoform X1
E3 ubiquitin-protein ligase RNF146 isoform X3
ethylmalonyl-CoA decarboxylase 1, transcript variant X6
ethylmalonyl-CoA decarboxylase 1, transcript variant X3
ethylmalonyl-CoA decarboxylase 1, transcript variant X4
ethylmalonyl-CoA decarboxylase 1, transcript variant X2
ethylmalonyl-CoA decarboxylase 1, transcript variant X1
ethylmalonyl-CoA decarboxylase 1, transcript variant X5
ethylmalonyl-CoA decarboxylase isoform X1
ethylmalonyl-CoA decarboxylase isoform X2
ethylmalonyl-CoA decarboxylase 1, transcript variant X7
uncharacterized LOC123280402, transcript variant X12
uncharacterized LOC123280402, transcript variant X15
uncharacterized LOC123280402, transcript variant X9
uncharacterized LOC123280402, transcript variant X11
uncharacterized LOC123280402, transcript variant X10
uncharacterized LOC123280402, transcript variant X14
ethylmalonyl-CoA decarboxylase 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
ethylmalonyl-CoA decarboxylase isoform X3
uncharacterized LOC123280402, transcript variant X21
uncharacterized LOC123280402, transcript variant X18
uncharacterized LOC123280402, transcript variant X20
uncharacterized LOC123280402, transcript variant X4
uncharacterized LOC123280402, transcript variant X17
uncharacterized LOC123280402, transcript variant X2
uncharacterized LOC123280402, transcript variant X16
uncharacterized LOC123280402, transcript variant X3
uncharacterized LOC123280402, transcript variant X19
uncharacterized LOC123280402, transcript variant X6
uncharacterized LOC123280402, transcript variant X7
uncharacterized LOC123280402, transcript variant X8
uncharacterized LOC123280402, transcript variant X1
uncharacterized LOC123280402, transcript variant X13
uncharacterized LOC123280402, transcript variant X5
uncharacterized protein KIAA0408 homolog
SOGA family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SOGA family member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SOGA family member 3, transcript variant X1
SOGA family member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 15% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: protein LEG1 homolog
protein LEG1 homolog, transcript variant X10
protein LEG1 homolog, transcript variant X7
protein LEG1 homolog, transcript variant X9
protein LEG1 homolog, transcript variant X11
protein LEG1 homolog, transcript variant X1
protein LEG1 homolog, transcript variant X3
protein LEG1 homolog, transcript variant X8
protein LEG1 homolog, transcript variant X2
protein LEG1 homolog, transcript variant X4
protein LEG1 homolog, transcript variant X5
protein LEG1 homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC106839029, transcript variant X1
uncharacterized LOC106839029, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: trace amine-associated receptor 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments